Office of the Commissioner of Food and Drugs; Delegation of Authority, 59196 [2012-23598]
Download as PDF
<![CDATA[
59196
Federal Register / Vol. 77, No. 187 / Wednesday, September 26, 2012 / Notices
Governors not later than October 22,
2012.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. United Community MHC,
Lawrenceburg, Indiana, proposes to
convert to stock form and merge with
United Community Bancorp,
Lawrenceburg, Indiana, an existing
savings and loan holding company. The
existing United Community Bancorp
will merge with a new company, also
called United Community Bancorp,
Lawrenceburg, Indiana, which will
become a savings and loan holding
company through the acquisition of 100
percent of the outstanding stock of
United Community Bank,
Lawrenceburg, Indiana, a federal
savings bank.
Board of Governors of the Federal Reserve
System, September 21, 2012.
Robert deV. Frierson,
Secretary of the Board.
[FR Doc. 2012–23706 Filed 9–25–12; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service (DHHS) is hereby giving notice
that the Presidential Advisory Council
on HIV/AIDS (PACHA) will hold a
meeting. The meeting will be open to
the public.
DATES: The meeting will be held
October 25, 2012 and October 26, 2012
from 9 a.m. to approximately 5 p.m.
(EDT).
ADDRESSES: Washington Marriott at
Metro Center, 775 12th Street NW.,
Washington, DC 20005–3901.
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, Public Health Assistant,
Presidential Advisory Council on HIV/
AIDS, Department of Health and Human
Services, 200 Independence Avenue
SW., Room 443H, Hubert H. Humphrey
Building, Washington, DC 20201; (202)
205–1178. More detailed information
about PACHA can be obtained by
accessing the Council’s Web site
www.aids.gov/pacha.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:27 Sep 25, 2012
Jkt 226001
PACHA
was established by Executive Order
12963, dated June 14, 1995 as amended
by Executive Order 13009, dated June
14, 1996. The Council was established
to provide advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to promote effective
prevention of HIV disease and AIDS.
The functions of the Council are solely
advisory in nature.
The Council consists of not more than
25 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
philanthropy, marketing or business, as
well as other national leaders held in
high esteem from other sectors of
society. Council members are appointed
by the Secretary or designee, in
consultation with the White House
Office on National AIDS Policy. The
agenda for the upcoming meeting will
be posted on the Council’s Web site at
www.aids.gov/pacha.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person. Preregistration for public attendance is
advisable and can be accomplished by
contacting Caroline Talev at
caroline.talev@hhs.gov. Members of the
public will have the opportunity to
provide comments at the meeting. Any
individual who wishes to participate in
the public comment session must
register with Caroline Talev at
caroline.talev@hhs.gov; registration for
public comment will not be accepted by
telephone. Public comment will be
limited to two minutes per speaker. Any
members of the public who wish to have
printed material distributed to PACHA
members at the meeting should submit,
at a minimum, 1 copy of the materials
to Caroline Talev, no later than close of
business Thursday, October 18, 2012.
Contact information for the PACHA
contact person is listed above.
SUPPLEMENTARY INFORMATION:
Dated: September 18, 2012.
B. Kaye Hayes,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. 2012–23720 Filed 9–25–12; 8:45 am]
BILLING CODE 4150–43–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0012]
Office of the Commissioner of Food
and Drugs; Delegation of Authority
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
Notice is hereby given that I have
delegated to the Commissioner of Food
and Drugs (the Commissioner) certain
authority added to the Public Health
Service Act by section 801 of Public
Law 110–85, the Food and Drug
Administration Amendments Act of
2007 (42 U.S.C. 282(j)), pertaining to the
expansion of the Clinical Trial Registry
and Results Data Bank described
therein. Specifically, the Commissioner
is delegated the following authority:
• Section 402(j)(5)(C)(ii) of the Public
Health Service Act (42 U.S.C.
282(j)(5)(C)(ii))—To determine that any
clinical trial information was not
submitted as required under 42 U.S.C.
282(j) or was submitted but is false or
misleading in any particular and to
notify the responsible party and give
such party an opportunity to remedy
non-compliance by submitting required
revised clinical trial information not
later than 30 days after such
notification.
This authority may be redelegated.
This delegation will be exercised in
accordance with the Department of
Health and Human Services’ applicable
policies, procedures, guidelines, and
regulations.
I ratify and affirm any actions taken
by the Commissioner or her
subordinates that involved the exercise
of the authority delegated herein prior
to the effective date of this delegation.
This delegation is effective upon date of
signature.
Dated: September 5, 2012.
Kathleen Sebelius,
Secretary of Health and Human Services.
[FR Doc. 2012–23598 Filed 9–25–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0001]
Anti-Infective Drugs Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
Frm 00034
Fmt 4703
Sfmt 4703
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 77, Number 187 (Wednesday, September 26, 2012)]
[Notices]
[Page 59196]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-23598]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0012]
Office of the Commissioner of Food and Drugs; Delegation of
Authority
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
Notice is hereby given that I have delegated to the Commissioner of
Food and Drugs (the Commissioner) certain authority added to the Public
Health Service Act by section 801 of Public Law 110-85, the Food and
Drug Administration Amendments Act of 2007 (42 U.S.C. 282(j)),
pertaining to the expansion of the Clinical Trial Registry and Results
Data Bank described therein. Specifically, the Commissioner is
delegated the following authority:
Section 402(j)(5)(C)(ii) of the Public Health Service Act
(42 U.S.C. 282(j)(5)(C)(ii))--To determine that any clinical trial
information was not submitted as required under 42 U.S.C. 282(j) or was
submitted but is false or misleading in any particular and to notify
the responsible party and give such party an opportunity to remedy non-
compliance by submitting required revised clinical trial information
not later than 30 days after such notification.
This authority may be redelegated. This delegation will be
exercised in accordance with the Department of Health and Human
Services' applicable policies, procedures, guidelines, and regulations.
I ratify and affirm any actions taken by the Commissioner or her
subordinates that involved the exercise of the authority delegated
herein prior to the effective date of this delegation. This delegation
is effective upon date of signature.
Dated: September 5, 2012.
Kathleen Sebelius,
Secretary of Health and Human Services.
[FR Doc. 2012-23598 Filed 9-25-12; 8:45 am]
BILLING CODE 4160-01-P
